1 |
Younes NA et al. (1111. Younes NA, Al-Trawneh IS, Albesoul NM, Hamdan BR, Sroujieh AS. Clinical spectrum of primary hyperparathyroidism. Saudi Med J. 2003;24(2):179-83.) |
Jordan |
1990-2002 |
40 |
70% had skeletal disease |
2 |
Ohe MN et al. (77. Ohe MN, Santos RO, Barros ER, Lage A, Kunii IS, Abrahão M, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002. Braz J Med Biol Res. 2005;38(9):1383-7.) |
Brazil |
1985-2002 |
104 |
53% symptomatic |
3 |
Malabu UH et al. (1212. Malabu UH, Founda MA. Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases. Med J Malaysia. 2007;62(5):394-7.) |
Saudi Arabia |
2000-2006 |
46 |
76% symptomatic |
4 |
Prasarttong-Osoth P et al. (1313. Prasarttong-Osoth P, Wathanaoran P, Imruetaicharoenchoke W, Rojananin S. Primary hyperparathyroidism: 11-year experience in a single institute in Thailand. Int J Endocrinol. 2012;2012:952426.) |
Thailand |
1997-2007 |
45 |
97.8% symptomatic |
5 |
Zhao L et al. (1414. Zhao L, Liu JM, He XY, Zhao HY, Sun LH, Tao B, et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab. 2013;98(2):721-8.) |
China |
2000-2010 |
249 |
61.4% symtomaic |
6 |
Paruk IM et al. (1515. Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad Med J. 2013;89(1057):626-31.) |
South Africa |
2003-2009 |
28 |
92.9% symptomatic |
7 |
Eufrazino et al. (1616. Eufrazino C, Veras A, Bandeira F. Epidemiology of Primary Hyperparathyroidism and its Non-classical Manifestations in the City of Recife, Brazil. Clin Med Insights Endocrinol Diabetes. 2013;6:69-74.) |
Brazil |
2007-2008 |
33 |
90% symtomatic but clasicalsymtoms only in 18.2% |
8 |
Shah VN et al. (1717. Shah VN, Bhadada S, Bhansali A, Behera A, Mittal BR. Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res. 2014;139(5):694-9.) |
India |
1990-2010 |
202 |
99.1% symtomatic |
9 |
Usta A et al. (1818. Usta A, Alhan E, Cinel A, Türkyilmaz S, Erem C. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015 Apr;100(4):648-55.) |
Turkey |
1993-2013 |
190 |
72.0% symtomatic |
10 |
Jha S et al. (1919. Jha S, Jayaraman M, Jha A, Jha R, Modi KD, Kelwadee JV. Primary hyperparathyroidism: A changing scenario in India. Indian J Endocrinol Metab. 2016;20(1):80-3.) |
India |
1994-2015 |
110 |
100% symtomatic |
11 |
Bhadada et al. (2020. Bhadada SK, Arya AK, Mukhopadhyay S, Khadgawat R, Sukumar S, Lodha S, et al. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab. 2018;36(2):238-45.) |
India |
2005-2015 |
464 |
95% symtomatic |
12 |
Ahsan T et al. (2121. Ahsan T, Erum U, Inam Pal KM, Jabeen R, Qureeshi SG, Rehman UL, Banu Z. The many guises of primary hyperparathyroidism: An unchanged scenario. J Pak Med Assoc. 2017 Apr; 67(4):580-5.) |
Pakistan |
2004-2014 |
25 |
96% symptomatic |
13 |
Yadav SK et al. (1010. Yadav SK, Mishra SK, Mishra A, Mayilvagnan S, Chand G, Agarwal G, et al. Changing Profile of Primary Hyperparathyroidism Over Two and Half Decades: A Study in Tertiary Referral Center of North India. World J Surg. 2018;42(9):2732-37.) |
India |
1990-2016 |
333 |
69% had musculoskeletal symtoms |
14 |
Bahrami A et al. (2222. Bahrami A, Montazeri V, Barband AR, Poorzand A, Mobaseri M. Advanced Bone Diseaseas the Most Common Clinical Presentationof Primary Hyperparathyroidism in Iranians:Clinical And Laboratory Features of62 Patients from North-Western Iran. Int JEndocrinol Metab.2006;4:19-29.) |
Iran |
1985-2002 |
62 |
100% symptomatic |
15 |
Bandeira F (2323. Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: The Brazilian experience. Arq Bras Endocrinol Metabol. 2006;50(4):657-63.) |
Brazil |
Not reorted |
90 |
57% symtomatic |
16 |
Bandeira F (2424. Bandeira F, Griz LH, Bandeira C, Pinho J, Lucena CS, Alencar C, et al. Prevalence of cortical osteoporosis in mild and severe primary hyperparathyroidism and its relationship with bone markers and vitamin D status. J Clin Densitom. 2009;12(2):195-9.) |
Brazil |
2000-2006 |
49 |
49% symtomatic |
17 |
Bandeira FA (2525. Bandeira FA, Oliveira RI, Griz LH, Caldas G, Bandeira C. Differences in accuracy of 99mTc-sestamibi scanning between severe and mild forms of primary hyperparathyroidism. J Nucl Med Technol. 2008 Mar;36(1):30-5.) |
Brazil |
2000-2005 |
64 |
61% had skeletal or/and renal disease |